Concepedia
Statistics
Publications
13
Citations
1.1K
H-Index
Active since
2009
Affiliations
Weizmann Institute of Science(Current)
University of Bergen
Haukeland University Hospital
Sheba Medical Center
Ira Kogan-Sakin is an author at Weizmann Institute of Science specializing in oncology, medicine, and molecular oncology.
Publications per year
2009–2018
Mutant p53R175H upregulates Twist1 expression and promotes epithelial–mesenchymal transition in immortalized prostate cells
Ira Kogan-Sakin, Yuval Tabach, Y Buganim et al. · Cell Death and Differentiation · 2010 · 152 citations · Full text
Medicine, Molecular Biology, Oncology +15
TMPRSS2/ERG Promotes Epithelial to Mesenchymal Transition through the ZEB1/ZEB2 Axis in a Prostate Cancer Model
Orit Leshem, Shalom Madar, Ira Kogan-Sakin et al. · PLoS ONE · 2011 · 122 citations · Full text
Life Sciences, Molecular Biology, Oncology +16
Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers
Hilla Solomon, Nathan Dinowitz, Ioannis S. Pateras et al. · Oncogene · 2018 · 117 citations · Full text
Medicine, Genetics, Oncology +15
p53 is required for brown adipogenic differentiation and has a protective role against diet-induced obesity
Alina Molchadsky, Osnat Ezra, Pier Giorgio Amendola et al. · Cell Death and Differentiation · 2013 · 114 citations · Full text
Medicine, Endocrinology, Molecular Genetics +15
Mutant p53R273H attenuates the expression of phase 2 detoxifying enzymes and promotes the survival of cells with high ROS levels
Eyal Kalo, Ira Kogan-Sakin, Hilla Solomon et al. · Journal of Cell Science · 2012 · 102 citations · Full text
Medicine, Cancer Biology, Oncology +17
1–5 of 13